US2022380814A1PendingUtilityA1

Method and System for Treatment of Microorganisms during Propagation, Conditioning, Fermentation, and Preservation Using Ethyl Lauroyl Arginate and Selected Additives

Assignee: ARCHANGEL INCPriority: Jul 6, 2015Filed: Aug 8, 2022Published: Dec 1, 2022
Est. expiryJul 6, 2035(~8.9 yrs left)· nominal 20-yr term from priority
Inventors:Allen Ziegler
Y02E50/10C07C 29/80C12P 7/10A23B 9/26A23B 9/28A01N 47/44A23V 2002/00C12N 1/18A23B 2/783A23B 2/762A23B 2/742A23B 2/729
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

What is disclosed is a method of reducing undesirable concentrations of microorganisms without the use of man-made antibiotics, comprising the steps of: introducing a quantity of fermentable carbohydrate; sugar or cellulose to an aqueous system; introducing a quantity of desirable microorganism to the aqueous system; introducing at least one acid into the aqueous system, wherein the at least one acid is selected from the group consisting of hops acid, organic acid, or a combination of hops acid and organic acid; and introducing a compound comprised of Lauryl-L-arginine ethyl ester monohydrochloride (LAE) into the aqueous system. The use of LAE as a preservative of distiller's grains and solubles is also disclosed.

Claims

exact text as granted — not AI-modified
1 - 70  (canceled) 
     
     
         71 . A method of reducing residual byproduct of antibiotic in a fermentation process, the method comprising the steps of:
 introducing a fermentable carbohydrate to an aqueous system;   introducing at least one desirable microorganism to said aqueous system; and   introducing at least one Ethyl Lauroyl Arginate compound into said aqueous system.   
     
     
         72 . The method of  claim 71 , further comprising the step of introducing at least one acid into said aqueous system,
 wherein the at least one acid is selected from the group consisting of hops acid, organic acid, or a combination of hops acid and organic acid.   
     
     
         73 . The method of  claim 71 , wherein the Ethyl Lauroyl Arginate compound is selected from the group consisting of LAEPro™, LAEPro™ S50, MIRENAT®-P/100, and MIRENAT®-GA. 
     
     
         74 . The method of  claim 71 , wherein said at least one desirable microorganism is selected from the group consisting of a yeast, a fungi, a bacteria, and combination thereof. 
     
     
         75 . The method of  claim 71 , wherein the steps are performed sequentially in the order provided in  claim 71 . 
     
     
         76 . The method of  claim 72 , wherein the concentration of the at least one acid in said aqueous fluid solution is in the range of 1 ppm to 100 ppm. 
     
     
         77 . The method of  claim 72 , wherein the concentration of the at least one acid in the aqueous fluid solution is in the range of 2 ppm to 70 ppm. 
     
     
         78 . The method of  claim 72 , wherein the dosage of the at least one acid is at least 0.5 ppm. 
     
     
         79 . The method of  claim 71 , wherein the Ethyl Lauroyl Arginate compound has a dosage of at least 0.5 ppm and less than or equal to 35 ppm. 
     
     
         80 . The method of  claim 72 , wherein the Ethyl Lauroyl Arginate compound is LAEPro™, LAEPro™ S50, MIRENAT®-P/100, and MIRENAT®-GA, and the ratio of the at least one acid to Ethyl Lauroyl Arginate compound is from 1:10 to 1:6500. 
     
     
         81 . A method of reducing residual byproduct of antibiotic in a fermentation process, the method comprising the steps of:
 introducing a fermentable carbohydrate to an aqueous system;   introducing at least one desirable microorganism to said aqueous system;   introducing at least one Ethyl Lauroyl Arginate compound into said aqueous system;   separating ethanol from whole stillage byproducts of fermentation and distillation processes; and   storing the separated ethanol, whereby the separated ethanol is substantially free of man-made antibiotics.   
     
     
         82 . The method of  claim 81 , further comprising the step of introducing at least one acid into said aqueous system,
 wherein the at least one acid is selected from the group consisting of hops acid, organic acid, or a combination of hops acid and organic acid.   
     
     
         83 . The method of  claim 81 , wherein the Ethyl Lauroyl Arginate compound is selected from the group consisting of LAEPro™, LAEPro™ S50, MIRENAT®-P/100, and MIRENAT®-GA. 
     
     
         84 . The method of  claim 81 , wherein said at least one desirable microorganism is selected from the group consisting of a yeast, a fungi, a bacteria, and combination thereof. 
     
     
         85 . The method of  claim 81 , wherein the steps are performed sequentially in the order provided in  claim 81 . 
     
     
         86 . The method of  claim 82 , wherein the concentration of the at least one acid in said aqueous fluid solution is in the range of 1 ppm to 100 ppm. 
     
     
         87 . The method of  claim 82 , wherein the concentration of the at least one acid in the aqueous fluid solution is in the range of 2 ppm to 70 ppm. 
     
     
         88 . The method of  claim 82 , wherein the dosage of the at least one acid is at least 0.5 ppm. 
     
     
         89 . The method of  claim 81 , wherein the Ethyl Lauroyl Arginate compound has a dosage of at least 0.5 ppm and less than or equal to 35 ppm. 
     
     
         90 . The method of  claim 82 , wherein the Ethyl Lauroyl Arginate compound is LAEPro™, LAEPro™ S50, MIRENAT®-P/100, and MIRENAT®-GA, and the ratio of the at least one acid to Ethyl Lauroyl Arginate compound is from 1:10 to 1:6500.

Join the waitlist — get patent alerts

Track US2022380814A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.